David Cragg - 09 Nov 2021 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Chief HR & Admin Officer
Signature
By: Robert Wong For: David Cragg
Issuer symbol
CYTK
Transactions as of
09 Nov 2021
Transactions value $
-$1,444,959
Form type
4
Filing time
09 Nov 2021, 16:35:14 UTC
Previous filing
02 Nov 2021
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $237K +24.5K +17.68% $9.65 163K 09 Nov 2021 Direct F1
transaction CYTK Common Stock Sale -$1.02M -24.5K -15.02% $41.76 139K 09 Nov 2021 Direct F1
transaction CYTK Common Stock Options Exercise $198K +20.5K +14.77% $9.65 159K 09 Nov 2021 Direct F1
transaction CYTK Common Stock Sale -$855K -20.5K -12.87% $41.76 139K 09 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Incentive Stock Option (right to buy) Options Exercise $0 -20.5K -100% $0.00* 0 09 Nov 2021 Common Stock 20.5K $9.65 Direct
transaction CYTK Non-Qualified Stock Option (right to buy) Options Exercise $0 -24.5K -100% $0.00* 0 09 Nov 2021 Common Stock 24.5K $9.65 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.